Drug therapy for advanced melanoma: a nursing perspective
The role of the skin cancer Clinical Nurse Specialist (CNS) in the UK is often confined to supporting patients with primary melanoma. The introduction of newly licensed drugs for advanced melanoma has provided new opportunities for the CNS to develop their expertise in this area. This
article describes the key contributions that the skin cancer CNS may play in caring for patients receiving drug therapy for advanced melanoma.
Keywords: ADVANCED MELANOMA; CLINICAL NURSE SPECIALIST (CNS); COMPLEX NURSING NEEDS; SYSTEMIC THERAPY
Document Type: Research Article
Publication date: 01 September 2015
- Dermatological Nursing is the quarterly, peer-reviewed journal of the British Dermatological Nursing Group (BDNG) and the UK's only quality dermatological nursing journal. It aims to provide cutting-edge articles on the treatment and management of dermatological conditions and the care of patients with skin problems. While the focus is on dermatological nursing, the information included is relevant to other healthcare professionals.
- Membership Information
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content